坎德沙坦基莱克塞提尔破坏了耐甲林的金黄色葡萄球菌膜,并增强了珍塔米辛和聚米辛B的活性
Nagendran Tharmalingam1,2,3, Robert Wilson Kovacs4, Suelen Scarpa de Mello5,6
1Department of Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Nature communications
|March 16, 2026
概括
康德沙坦西莱克塞特 (CC) 通过改变脂质组成和基因表达来破坏甲素耐药黄金葡萄球菌 (MRSA) 膜平衡. 这种重新设计的药物显示出作为一种新型抗菌剂对抗耐药细菌的潜力.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 构成了重大的全球卫生挑战,原因是多药耐药性导致的治疗选择有限.
- 抗高血压药物Candesartan cilexetil (CC) 已显示出强烈的抗MRSA活性,包括膜透和氨基甘油酸抗生素的强化.
研究的目的:
- 阐明康德沙坦基列 (CC) 干扰MRSA膜恒温的作用机制.
- 研究特定分子成分和脂肪酸在CC抗菌活性中的作用.
- 在临床前MRSA感染模型中评估CC的疗效.
主要方法:
- 膜生物物理测试评估CC与脂质双层和膜流动性的相互作用.
- 转录组和代谢组分析以确定受影响的细胞通路.
- 结构-活动关系研究以确定CC的关键功能组.
- 在小鼠MRSA模型中进行体内疗效测试.
主要成果:
- CC与脂质双层结合,降低了膜流动性,并降低了与细胞膜和细胞壁合成相关的基因和代谢物.
- 脂肪酸C20的减少 (C20:0) 赋予了对CC的耐药性,在补充后可以逆转.
- 醇环和碳酸部分的CC对于其抗菌活性至关重要.
- 在小鼠瘤模型中,CC治疗显著降低了MRSA-MW2复制.
结论:
- 坎德沙坦基莱克塞特 (CC) 通过特定的分子相互作用和代谢变化破坏MRSA膜完整性和稳态.
- 该研究确定C20:0脂肪酸水平是CC耐药性的关键因素,并突出了CC对其抗菌功能的关键结构特征.
- 作为一种独立的抗微生物药物或对MRSA感染的强化剂,CC显示出治疗潜力,需要进一步调查.
相关概念视频
Combined Effects of Drugs: Synergism
7.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.2K
Pharmacokinetics: Drug–Drug Interactions
606
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
606
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
308
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
308
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
71
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
71
Development of Antibiotic Resistance
1.8K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K


